Trial intelligence / Profile preview

Bacillus clausii for prevention of antibiotic-associated diarrhea in children

PACTR202406832389998Phase 2Completed

Sponsor
Cairo University
Start
Jan 2021
Modality
Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Countries
1
01

Overview

Phase 2 trial of bacillus clausii in antibiotic-associated diarrhea (AAD) (2 arms), sponsored by Cairo University. Started Jan 2021; status: completed.

02

Drugs

bacillus clausii
03

Conditions

antibiotic-associated diarrhea (AAD)

Beyond the preview

Go deeper on PACTR202406832389998.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202406832389998.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call